| Literature DB >> 18548000 |
J S Li1, C M Baker-Smith, P B Smith, V Hasselblad, M D Murphy, R M Califf, D K Benjamin.
Abstract
Angiotensin-converting enzyme (ACE) inhibitors are frequently used to treat hypertension in children.(1) ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive, and cardiac hypertrophic properties of angiotensin II and the vasodilatory and natriuretic properties of bradykinin; they also alter the metabolism of other vasoactive substances.(2) Through these mechanisms, ACE inhibitors decrease systemic vascular resistance and promote natriuresis without increasing heart rate. This study evaluated the results of six trials of ACE inhibitors in children, using meta-analytic techniques to estimate the effect of race on blood pressure response.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18548000 PMCID： PMC2614386 DOI： 10.1038/clpt.2008.113
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN： 0009-9236 Impact factor: 6.875